MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Clinical trials for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists hunt clues to unlock stomach Cancer's immune resistance
Disease control Not yet recruitingThis study aims to understand why some patients with a specific type of stomach cancer respond well to immunotherapy while others do not. It will enroll 15 Asian patients with this cancer type who are scheduled for surgery after receiving immunotherapy. The goal is to learn what …
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Two-Pronged attack on stomach cancer before surgery
Disease control Not yet recruitingThis study aims to see if one of two different drug combinations can help shrink tumors before surgery for people with a specific type of advanced stomach or gastroesophageal cancer. About 30 participants will be randomly assigned to receive either an immunotherapy drug plus chem…
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC